AxoGen Inc
NASDAQ:AXGN
AxoGen Inc
Goodwill
AxoGen Inc
Goodwill Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Goodwill | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AxoGen Inc
NASDAQ:AXGN
|
Goodwill
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Goodwill
$18.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Goodwill
$1.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
Stryker Corp
NYSE:SYK
|
Goodwill
$19.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
17%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Goodwill
$24B
|
CAGR 3-Years
2%
|
CAGR 5-Years
0%
|
CAGR 10-Years
10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Goodwill
$370.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
AxoGen Inc
Glance View
Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 428 full-time employees. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair a variety of physical nerve damage or transection throughout the body, which ranges from a simple laceration of a finger to a complex brachial plexus injury, as well as nerve injuries caused by dental, orthopedic, and other surgical procedures. Its Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Its portfolio of products is available in the United States, Canada, Germany, Spain, South Korea, and several other countries.
